JPWO2022243937A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022243937A5 JPWO2022243937A5 JP2023571449A JP2023571449A JPWO2022243937A5 JP WO2022243937 A5 JPWO2022243937 A5 JP WO2022243937A5 JP 2023571449 A JP2023571449 A JP 2023571449A JP 2023571449 A JP2023571449 A JP 2023571449A JP WO2022243937 A5 JPWO2022243937 A5 JP WO2022243937A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163191076P | 2021-05-20 | 2021-05-20 | |
| US63/191,076 | 2021-05-20 | ||
| PCT/IB2022/054701 WO2022243937A1 (en) | 2021-05-20 | 2022-05-19 | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024520202A JP2024520202A (ja) | 2024-05-22 |
| JPWO2022243937A5 true JPWO2022243937A5 (https=) | 2025-05-28 |
| JP2024520202A5 JP2024520202A5 (https=) | 2025-05-28 |
Family
ID=81927398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571449A Pending JP2024520202A (ja) | 2021-05-20 | 2022-05-19 | Ｉｌ－２３に対する抗体及びｔｎｆアルファに対する抗体の組み合わせ療法を用いた炎症性腸疾患を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220372129A1 (https=) |
| EP (1) | EP4340875A1 (https=) |
| JP (1) | JP2024520202A (https=) |
| KR (1) | KR20240012469A (https=) |
| CN (1) | CN118076385A (https=) |
| AU (1) | AU2022276189A1 (https=) |
| BR (1) | BR112023024064A2 (https=) |
| CA (1) | CA3220618A1 (https=) |
| IL (1) | IL308607A (https=) |
| MX (1) | MX2023013788A (https=) |
| WO (1) | WO2022243937A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020234834A1 (en) | 2019-05-23 | 2020-11-26 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
| KR20230023663A (ko) | 2020-05-21 | 2023-02-17 | 얀센 바이오테크 인코포레이티드 | Il-23 및 tnf 알파에 대한 항체의 병용 요법으로 염증성 장질환을 치료하는 방법 |
| WO2024228134A1 (en) * | 2023-05-03 | 2024-11-07 | Janssen Biotech, Inc. | Method of treating ulcerative colitis with a combination of antibodies to il-23 and tnf alpha |
| EP4704895A1 (en) * | 2023-05-03 | 2026-03-11 | Janssen Biotech, Inc. | Method of treating crohn's disease with a combination of antibodies to il-23 and tnf alpha |
| WO2025024723A1 (en) * | 2023-07-26 | 2025-01-30 | Sorriso Pharmaceuticals, Inc. | Il-23 and tnf-alpha induction treatment for autoimmune and inflammatory disorders |
| WO2025076251A1 (en) * | 2023-10-05 | 2025-04-10 | Sorriso Pharmaceuticals, Inc. | Dosages of il-23 and tnf-alpha inhibitors for use in autoimmune and inflammatory disorders |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB2183661B (en) | 1985-03-30 | 1989-06-28 | Marc Ballivet | Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| EP0279582A3 (en) | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP1291360A1 (en) | 1991-12-13 | 2003-03-12 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| US6309663B1 (en) | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| AU2006265002B2 (en) | 2005-06-30 | 2012-09-20 | Centocor, Inc. | Anti-IL-23 antibodies, compositions, methods and uses |
| WO2017132457A1 (en) | 2016-01-28 | 2017-08-03 | Janssen Biotech, Inc. | BISPECIFIC ANTI-TNF-α/IL-17A ANTIBODIES AND ANTI-TNF-α ANTIBODIES AND METHODS OF THEIR USE |
| EP3519049B1 (en) | 2016-09-30 | 2025-12-03 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-il23 specific antibody |
| TWI837532B (zh) * | 2018-03-30 | 2024-04-01 | 美商美國禮來大藥廠 | 治療潰瘍性結腸炎之方法 |
| WO2020234834A1 (en) * | 2019-05-23 | 2020-11-26 | Janssen Biotech, Inc. | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
| KR20230023663A (ko) * | 2020-05-21 | 2023-02-17 | 얀센 바이오테크 인코포레이티드 | Il-23 및 tnf 알파에 대한 항체의 병용 요법으로 염증성 장질환을 치료하는 방법 |
-
2022
- 2022-05-19 EP EP22727462.8A patent/EP4340875A1/en active Pending
- 2022-05-19 CA CA3220618A patent/CA3220618A1/en active Pending
- 2022-05-19 WO PCT/IB2022/054701 patent/WO2022243937A1/en not_active Ceased
- 2022-05-19 BR BR112023024064A patent/BR112023024064A2/pt unknown
- 2022-05-19 JP JP2023571449A patent/JP2024520202A/ja active Pending
- 2022-05-19 IL IL308607A patent/IL308607A/en unknown
- 2022-05-19 MX MX2023013788A patent/MX2023013788A/es unknown
- 2022-05-19 KR KR1020237043829A patent/KR20240012469A/ko active Pending
- 2022-05-19 AU AU2022276189A patent/AU2022276189A1/en active Pending
- 2022-05-19 CN CN202280050683.4A patent/CN118076385A/zh active Pending
- 2022-05-19 US US17/748,629 patent/US20220372129A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7579227B2 (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| US7709611B2 (en) | Antibodies to Dkk-1 | |
| JP2021526534A5 (https=) | ||
| JP2020500152A5 (https=) | ||
| JPWO2020234834A5 (https=) | ||
| UA128578C2 (uk) | Способи лікування неспецифічного виразкового коліту | |
| JP2021502349A5 (https=) | ||
| JP2021515770A5 (https=) | ||
| US12098207B2 (en) | Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum | |
| JP2020502261A5 (https=) | ||
| JP2019528306A5 (https=) | ||
| JP2022547452A (ja) | Ａｃｔｒｉｉ受容体拮抗薬を含む肝疾患または肝臓障害の治療 | |
| CN106573056A (zh) | 用于诊断和治疗炎症性肠病的方法和组合物 | |
| JPWO2019200256A5 (https=) | ||
| JPWO2021234634A5 (https=) | ||
| JP4316886B2 (ja) | 全身性エリテマトーデスの治療のための合成ヒトペプチド及びそれらを含む医薬組成物 | |
| JPWO2022243937A5 (https=) | ||
| EP4442273A1 (en) | Method for preventing and/or treating thromboembolic diseases | |
| EP3345924A1 (en) | Use of cd47 antibodies | |
| CN112915203A (zh) | 喹啉衍生物与pd-1单抗的药物组合 | |
| US20230049147A1 (en) | Anti-il-36r antibodies for the treatment of a fibrotic condition | |
| JPWO2019171252A5 (https=) | ||
| CN112351996A (zh) | 用于治疗应激相关病症和癌症的材料和方法 | |
| EP4204086A1 (en) | Anti-fibrotic combination | |
| JPWO2022074603A5 (https=) |